ArticlePloS one2026

Surveillance of hepatocellular carcinoma (HCC) patients using Protein Induced by Vitamin K (PIVKA-II): A cost-utility analysis for Hong Kong.

Man-Fung Yuen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.